Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

CDC Doc: Meningitis Outbreak Rivaled Ebola Epidemic

By MaryBeth DiDonna | January 11, 2017

The trial of two pharmacists who oversaw a compounding center deemed responsible for a deadly meningitis outbreak continues this week, with a government doctor comparing the crisis to the devastating Ebola outbreak in Africa.

Dr. Benjamin Park, a division chief at the U.S. Center for Disease Control and Prevention, testified on Tuesday at the trial of New England Compounding Center owner and president Barry Cadden. Cadden is facing 25 counts of murder for the 2012 fungal meningitis outbreak, which resulted from steroids compounded by NECC. He is also facing racketeering charges. The outbreak killed 64 people and sickened over 700 others.

Read more: Pharmacists from Fatal Meningitis Outbreak Facing Trial

“In my 15 years of being at the CDC investigating outbreaks, the only thing that rises to this level was the Ebola outbreak,” he said. “This one was here in our country, and it was entirely preventable.”

Prosecutors say that the center used expired ingredients and did not follow cleanliness standards, which resulted in the tainted steroid injections. State officials and the FDA have released reports detailing the unsatisfactory conditions in the facility’s cleanroom, including puddles of water and dirty mats on the floor.

“I remember feeling very scared,” Park said, speaking about a “massive effort” between state and local health officials to contact the potential 14,000 victims of the moldy injections. Park testified that authorities reduced the death rate to 5 percent or less after they discovered the cause of the infections.

Cadden’s lawyer, Bruce Singal, maintain his client’s innocence. He told the jury that, while Cadden oversaw the company’s operations, but didn’t work in the cleanroom or mix the drugs. Singal produced emails that Cadden had sent to a cleaning company, scolding them for not following sterility guidelines when cleaning the cleanroom.

The trial is expected to last several more months. Former NECC head pharmacist Glenn Chin will go to trial once Cadden’s is over. Chin is also facing numerous murder charges for his alleged role in the outbreak.

Related Articles Read More >

6 essentials for seismic rated cleanrooms
Critical Spaces Control Platform
Phoenix Critical Spaces Control Platform uses automation to direct airflow
Endiatx
Endiatx aims to boldly go beyond traditional endoscopy and, eventually, redefine surgical scale
FMN Laboratory researcher in a cleanroom
Take our quiz to test your cleanroom IQ, covering everything from ISO Classes to ULPA filtration
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE